Overview
- 17 inspections across 17 sites are on record.
- 13 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-12-12.
At a glance
Inspections
17
Sites
17
Observations
13
Career since
May 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC | 12 Dec 2024 | Human Drugs | |
| Nordic Pharma, Inc. | 16 Nov 2023 | Human Drugs | |
| Robert Nossa, M.D. | 8 Dec 2022 | Human Drugs | |
| Patricia Kropf MD | 21 Oct 2020 | Human Drugs | View 483 → |
| Yuchi Han, MD | 12 Apr 2019 | Human Drugs |
Sites inspected
SUN PHARMACEUTICAL INDUSTRIES INCPrinceton, United States1 insp.
Nordic Pharma, Inc.Berwyn, United States1 insp.
Robert Nossa, M.D.Verona, United States1 insp.
Patricia Kropf MDPhiladelphia, United States1 insp.
Yuchi Han, MDPhiladelphia, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Joseph L Despins3 shared
Charisse K Green3 shared
Debra M Emerson3 shared
Marcelo O Mangalindan2 shared
Ileana Barreto-Pettit2 shared
Russell J Glapion1 shared
Full investigator report
Get the verbatim findings behind Rochelle L Cross' 13 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site